ArticleAnnals of nuclear medicine2026
Association of global gray matter volume and cortical thickness with cognitive function stratified by amyloid PET status.
Article in Annals of nuclear medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
objectiveStructural magnetic resonance imaging (MRI) measures may relate to cognition differently depending on the underlying biological context. We examined the associations of global gray matter volume and cortical thickness with cognitive performance after stratification by amyloid positron emission tomography (PET) status.
methodsThis cross-sectional study included 113 participants (mean age 76.3 ± 7.8 years; 68.1% female) who underwent amyloid PET, structural MRI, and Mini-Mental State Examination (MMSE). Amyloid burden was quantified on the Centiloid scale, with positivity defined as > 25 (44 amyloid-negative, 69 amyloid-positive). Global gray matter volume normalized by total intracranial volume (GM/TIV) and global cortical thickness were derived with CAT12/SPM12. Multivariable linear regression was used to assess associations with the MMSE score after adjustment for age, sex, and amyloid burden, with prespecified stratification by amyloid status. Formal interaction analyses tested effect modification.
resultsIn the overall cohort, GM/TIV was independently associated with the MMSE score (β = 0.35, p = 0.007), whereas cortical thickness was not (β = 0.02, p = 0.844). In exploratory stratified analyses, GM/TIV was associated with the MMSE score in amyloid-positive participants (β = 0.48, p = 0.003) but not in amyloid-negative participants (β = 0.05, p = 0.835). Age was associated with the MMSE score in amyloid-negative participants (β = -0.33, p = 0.041) but not in amyloid-positive participants (β = 0.11, p = 0.377). Formal interaction analyses were not significant.
conclusionsIn this cohort, global GM/TIV was associated with cognitive performance more consistently than global cortical thickness. Exploratory stratified analyses suggested different association patterns according to amyloid PET status; however, formal interaction analyses were not significant. These findings should therefore be interpreted cautiously and validated in larger longitudinal studies.
Indexed as
Identifiers
42696260What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.